U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Webinar: OPDP Electronic Submissions – Common Errors in eCTD and How to Avoid Them- Oct. 25, 2019 - 10/25/2019
  1. News & Events for Human Drugs

Webcast | Virtual

Event Title
Webinar: OPDP Electronic Submissions – Common Errors in eCTD and How to Avoid Them- Oct. 25, 2019
October 25, 2019

Date:
October 25, 2019
Time:
1:00 p.m. ET

Follow us on LinkedIn

View Slides

This webinar is FREE. This webinar was recorded on Oct. 25, 2019.

ABOUT

This presentation provides an overview on:

  1. the most common types of errors seen in promotional submissions in eCTD format,
  2. how submitters can identify those errors prior to submitting, and
  3. services provided by the Office of Prescription Drug Promotion (OPDP) to assist submitters who have questions related to the structure and data requirements associated with promotional submissions in eCTD format.

Now that FDA accepts promotional submissions in eCTD format, the agency’s goal is to reduce the time required to process submissions and route files from to the reviewer as quickly as possible.  While a promotional submission may pass validation at the electronic submissions gateway (ESG), it is possible for coding errors in the accompanying files to result in manual processing of the submission. Any failures during the automated processing can lead to delays in the delivery of promotional materials to the OPDP reviewer.

TOPICS COVERED

  • Most common errors
    • Global errors
    • Submission type specific errors
    • Content and presentation errors
  • Quality control and how to spot errors prior to submitting
  • OPDP eCTD services and test submission process

LEARNING OBJECTIVES

  • Identify the common errors that will result in failure of the automated processing of Promotional Submissions in eCTD format
  • Evaluate quality control strategies and incorporate best practices into existing eCTD publishing processes
  • Compare and assess the various services provided by OPDP’s eCTD team to support eCTD Submitters

INTENDED AUDIENCE

  • eCTD submitters
  • Ad/Promo regulatory operations managers
  • Ad/Promo publishers
  • Ad/Promo consultants

FDA SPEAKER

Jason Cober
Lead Project Manager
Office of Prescription Drug Promotion (OPDP) | CDER | FDA 

FDA RESOURCE

Final Guidance - Providing Regulatory Submissions in Electronic and Non-Electronic Format – Promotional Labeling and Advertising Materials for Human Prescription Drugs

 

Event Materials

Title File Type/Size
Promotional Submissions in eCTD Format PDF pdf (238.18 KB)
Back to Top